Susquehanna International Group
LABD icon

Susquehanna International Group’s Direxion Daily S&P Biotech Bear 3X ETF LABD Stock Holding History

Susquehanna International Group’s Portfolio LABD Stock Details LABD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.8M Sell
909,200
-196,900
-18% -$3.73M ﹤0.01% 2577
2025
Q4 		$23.3M Sell
1,106,100
-301,200
-21% -$8.17M ﹤0.01% 2046
2025
Q3 		$56.9M Buy
1,407,300
+1,282,290
+1,026% +$74.3M 0.01% 1250
2025
Q2 		$9.35M Buy
125,010
+53,980
+76% +$4.77M ﹤0.01% 2922
2025
Q1 		$6.7M Buy
71,030
+27,070
+62% +$1.98M ﹤0.01% 3124
2024
Q4 		$3.19M Sell
43,960
-23,030
-34% -$1.41M ﹤0.01% 4376
2024
Q3 		$3.91M Buy
66,990
+24,240
+57% +$1.47M ﹤0.01% 4041
2024
Q2 		$3.13M Sell
42,750
-99,590
-70% -$8.41M ﹤0.01% 4225
2024
Q1 		$10.4M Buy
142,340
+80,760
+131% +$6.74M ﹤0.01% 2548
2023
Q4 		$5.97M Buy
61,580
+6,970
+13% +$1.36M ﹤0.01% 3416
2023
Q3 		$11.2M Sell
54,610
-19,010
-26% -$3.09M ﹤0.01% 2399
2023
Q2 		$10.6M Buy
73,620
+45,620
+163% +$6.81M ﹤0.01% 2442
2023
Q1 		$5.77M Sell
28,000
-18,010
-39% -$3.06M ﹤0.01% 3243
2022
Q4 		$7.94M Sell
46,010
-19,740
-30% -$4.05M ﹤0.01% 2578
2022
Q3 		$15.7M Buy
65,750
+22,110
+51% +$5.14M ﹤0.01% 1649
2022
Q2 		$17M Buy
43,640
+18,120
+71% +$9.09M ﹤0.01% 1592
2022
Q1 		$8.95M Sell
25,520
-26,420
-51% -$10.4M ﹤0.01% 2697
2021
Q4 		$13.4M Sell
51,940
-3,080
-6% -$708K ﹤0.01% 2321
2021
Q3 		$11.7M Buy
55,020
+7,770
+16% +$1.65M ﹤0.01% 2641
2021
Q2 		$9.12M Buy
47,250
+1,160
+3% +$260K ﹤0.01% 3062
2021
Q1 		$10M Sell
46,090
-9,760
-17% -$1.89M ﹤0.01% 2765
2020
Q4 		$14.1M Sell
55,850
-6,380
-10% -$2.43M ﹤0.01% 2100
2020
Q3 		$37.1M Buy
62,230
+60,791
+4,225% +$39.2M 0.01% 1038
2020
Q2 		$999K Buy
1,439
+600
+72% +$754K ﹤0.01% 5922
2020
Q1 		$2.36M Sell
839
-4,415
-84% -$12.6M ﹤0.01% 3684
2019
Q4 		$13M Buy
5,254
+495
+10% +$1.76M ﹤0.01% 1818
2019
Q3 		$24.1M Buy
4,759
+10
+0.2% +$41.2K 0.01% 1202
2019
Q2 		$17.1M Sell
4,749
-160
-3% -$674K 0.01% 1403
2019
Q1 		$18.1M Sell
4,909
-150
-3% -$727K 0.01% 1270
2018
Q4 		$43.3M Buy
5,059
+974
+24% +$7.15M 0.02% 665
2018
Q3 		$19.9M Sell
4,085
-162
-4% -$782K 0.01% 1331
2018
Q2 		$22M Buy
4,247
+191
+5% +$1.16M 0.01% 1218
2018
Q1 		$29.6M Buy
4,056
+3,971
+4,672% +$27.6M 0.01% 948
2017
Q4 		$780K Buy
85
+45
+113% +$448K ﹤0.01% 5732
2017
Q3 		$370K Buy
40
+26
+186% +$314K ﹤0.01% 7044
2017
Q2 		$191K Sell
14
-1
-7% -$19.2K ﹤0.01% 8330
2017
Q1 		$307K Sell
15
-30
-67% -$741K ﹤0.01% 7298
2016
Q4 		$1.69M Sell
45
-47
-51% -$1.81M ﹤0.01% 4429
2016
Q3 		$3.18M Buy
92
+39
+74% +$1.82M ﹤0.01% 2815
2016
Q2 		$3.89M Sell
53
-2
-4% -$161K ﹤0.01% 2549
2016
Q1 		$5.88M Buy
55
+17
+45% +$2.18M ﹤0.01% 2103
2015
Q4 		$2.33M Buy
+38
New +$2.9M ﹤0.01% 3735

Other funds holding LABD

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
CCM
Capstone Capital Management Hong Kong $224M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Susquehanna International Group's LABD Position: Q1 2026 in Review

Susquehanna International Group reduced its Direxion Daily S&P Biotech Bear 3X ETF (LABD) stake by 48% in Q1 2026, selling an estimated $398K and leaving 22,711 shares worth $370K. The position accounts for ﹤0.01% of the portfolio, ranked #10403.

Susquehanna International Group first reported a position in LABD in Q3 2015 and has held it in 38 quarters since. The position peaked at $13.4M in Q3 2022. 17 funds tracked by Wall St. Rank hold LABD as of Q1 2026.

  • Susquehanna International Group held 22,711 shares of Direxion Daily S&P Biotech Bear 3X ETF worth $370K as of Q1 2026.
  • Susquehanna International Group sold 21,037 Direxion Daily S&P Biotech Bear 3X ETF shares in Q1 2026, an estimated $398K.
  • Direxion Daily S&P Biotech Bear 3X ETF made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #10403 holding.
  • Susquehanna International Group first reported a position in Direxion Daily S&P Biotech Bear 3X ETF in Q3 2015 and has held it in 38 quarters since.
  • Susquehanna International Group's Direxion Daily S&P Biotech Bear 3X ETF position peaked at $13.4M in Q3 2022.
  • 17 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bear 3X ETF as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.